MAK Capital One »

Caris Life Sciences shares owned by MAK Capital One

Quarter-by-quarter ownership of Caris Life Sciences (CAI) shares owned by MAK Capital One from 13F filings

Historical chart of MAK Capital One investment in Caris Life Sciences

Tip: Access up to 7 years of quarterly data

All positions including Caris Life Sciences held by MAK Capital One consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Caris Life Sciences by MAK Capital One

Quarter filed Position value Share count Share price at filing
2026-06-30 $35M 1.9M 17.82

More positions owned by MAK Capital One

Agilysys (AGYS)
Grupo Financiero Galicia Sponsored Adr (GGAL)
Acadia Healthcare (ACHC)
Uniqure Nv SHS (QURE)
Skyline Corporation (SKY)
Autolus Therapeutics Spon Ads (AUTL)
Clearpoint Neuro (CLPT)
Grupo Supervielle Sponsored Adr (SUPV)
Caris Life Sciences (CAI)
Annexon (ANNX)
D Fluidigm Corp Del (LAB)
Comstock Com Shs (LODE)
Cryoport Com Par $0.001 (CYRX)
Honest (HNST)
Cenovus Energy (CVE)

View all positions for MAK Capital One

Top funds holding Caris Life Sciences

FMR
Sixth Street Partners Management Company
J. H. Whitney Equity Partners VI
Coatue Management
Braidwell
PointState Capital
Jpmorgan Chase & Co
BlackRock
Vanguard Portfolio Management
T. Rowe Price Associates
Vanguard Capital Management
Neuberger Berman Group
OrbiMed Advisors
UBS Group
Thomas Stevens, CFA"

View all funds holding Caris Life Sciences